ZYNERBA PHARMACEUTICALS INC (ZYNE) Earnings History & Surprises

NASDAQ:ZYNE • US98986X1090

Current stock price

1.3 USD
+0.03 (+2.36%)
At close:
1.3015 USD
+0 (+0.12%)
After Hours:

ZYNE Earnings overview

Past quarterly earnings results for ZYNERBA PHARMACEUTICALS INC (ZYNE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Nov 13, 2023
Period
Q3 / 2023
EPS Estimate
$0.09
Revenue Estimate
15.3M

Last Reported

Most Recent
Release Date
Aug 14, 2023
Period
Q2 / 2023
EPS Reported
-$0.21
EPS Surprise
-4.68%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2023 -0.21 -0.20 -4.68% 12.50% - -
Q1 2023 -0.21 -0.19 -8.36% - - -
Q4 2022 -0.18 -0.19 4.61% 18.18% - -
Q3 2022 -0.20 -0.23 12.85% 23.08% - -
Q2 2022 -0.24 -0.23 -2.75% 4.00% - -
Q1 2022 -0.21 -0.23 10.02% -5.00% - -
Q4 2021 -0.22 -0.27 18.09% 33.33% - -
Q3 2021 -0.26 -0.26 -1.15% 16.13% - -
Q2 2021 -0.25 -0.24 -2.98% 67.95% - -
Q1 2021 -0.20 -0.25 21.39% 62.26% - -
Q4 2020 -0.33 -0.34 1.53% - - -
Q3 2020 -0.31 -0.44 29.74% - - -
Q2 2020 -0.78 -0.46 -70.96% - - -
Q1 2020 -0.53 -0.51 -4.52% - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ZYNE EPS Q2Q GrowthZYNE EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 0 100 -100 -200 -300

Revenue Historical Q2Q growth and Acceleration

ZYNE Revenue Q2Q GrowthZYNE Revenue Q2Q GrowthRevenue Q2Q Growth Q3/24 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
1.11%
Max EPS beat (4)
12.85%
Min EPS beat (4)
-8.36%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, ZYNE has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, ZYNE has beaten the EPS estimates by 1.1% on average.
ZYNE Overview ZYNE Technical Analysis Report ZYNE Fundamental Analysis Report ZYNE Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ZYNERBA PHARMACEUTICALS INC / ZYNE Earnings FAQ

What is the most recent earnings date for ZYNE stock?

ZYNERBA PHARMACEUTICALS INC (ZYNE) last reported earnings on 8/14/2023.

Did ZYNERBA PHARMACEUTICALS INC (ZYNE) beat earnings estimates last quarter?

ZYNERBA PHARMACEUTICALS INC (ZYNE) missed EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often ZYNERBA PHARMACEUTICALS INC beats earnings estimates?

In the last 4 quarters, ZYNERBA PHARMACEUTICALS INC (ZYNE) has beaten EPS estimates in 2 out of 4 releases.